Related Experiment Video
Updated: Jun 19, 2026

Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
FACTORS INFLUENCING THE PERSISTENCE OF CHORIOMENINGITIS VIRUS IN THE BLOOD OF MICE AFTER CLINICAL RECOVERY
1Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey.
Abstract:
Mice infected in utero continued to carry choriomeningitis virus in the blood more regularly and in greater amount than suckling mice infected by contact. This result may be due to the difference in tissue maturity at the time of infection: the more immature the tissues are when infected, the longer the virus appears to persist in them after maturation. A similar result was obtained with mice of different ages infected either by contact or by intranasal instillation of virus, in that the carrier state lasted longer in the younger animals. This cannot be attributed entirely to the difference in age, however, since young mice as a rule showed more severe symptoms than mature animals. It is possible, therefore, that the difference in the severity of the disease accounted in part for that in the duration of the infection. In mature mice infected experimentally as well as in some of the suckling mice infected by contact the severity of the disease was the determining factor, the infection persisting longest in those animals that showed the most severe reaction. The character of the virus used also appeared to influence the persistence of the virus in the blood. A strain of virus isolated in 1935 from an infected stock mouse and modified by intracerebral passage in mice (5) disappeared from the circulation more rapidly than the stock strain maintained by natural passage in the infected mouse stock. The guinea pig passage strain, however, which was obtained from the same mouse as the mouse passage virus but passed through guinea pigs by pad inoculation, persisted in the blood more frequently than the stock strain. Carrier mice without exception had a high degree of immunity to intracerebral injection with virus, while other animals once infected but no longer carrying detectable amounts of virus in the blood often showed an incomplete immunity that manifested itself in an accelerated, non-fatal reaction, presumably of an allergic nature. This observation does not prove, however, that the immunity always is an "infection immunity," since a high degree of resistance not associated with detectable amounts of virus in the blood and brain was produced by repeated injections with the mouse passage strain. Since the blood and the tissues of old carriers often contain large amounts of virus, it is very unlikely that their immunity is due to protective antibodies circulating in the blood or fixed in the tissue spaces. It rather appears that the susceptible cells of such animals are infected and that cells occupied by actively multiplying virus cannot be reinfected. The mechanism of this infection immunity as well as the immunity apparently not associated with infection requires further study.
Insights
Mice infected in utero or at younger ages develop longer-lasting lymphocytic choriomeningitis virus (LCMV) infections. Disease severity and viral strain also influence infection duration and immunity development in mice.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Lymphocytic choriomeningitis virus (LCMV) is a significant pathogen in mouse models.
- Understanding factors influencing LCMV persistence and host immunity is crucial for disease control.
Purpose of the Study:
- To investigate how age, route of infection, and viral strain affect LCMV persistence in mice.
- To explore the nature of immunity developed in LCMV-infected mice.
Main Methods:
- Mice were infected in utero, as sucklings, or at different ages via contact or intranasal instillation.
- Different LCMV strains (stock, mouse-passaged, guinea pig-passaged) were used.
- Viral load in blood and host immune responses were assessed.
Main Results:
- In utero and early-life infections led to more persistent viremia compared to infections in mature mice.
- Younger mice and those with more severe disease generally had longer-lasting infections.
- Viral strain influenced persistence; guinea pig-passaged strain persisted longer than stock or mouse-passaged strains.
- Carrier mice exhibited strong immunity, while non-carriers often showed incomplete or allergic reactions.
Conclusions:
- Tissue maturity at infection, disease severity, and viral strain are key determinants of LCMV persistence.
- Immunity in chronic carriers may involve cellular mechanisms (infection immunity) rather than solely circulating antibodies.
- Further research is needed to elucidate the mechanisms of both infection immunity and non-infection-associated resistance in LCMV.

